LVTX

LAVA Therapeutics NV News - LVTX

Buy
Sell
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
US$80.29
USA Small Cap Basic
Monthly Subscription
for only
US$33.03
USA Big Cap Pro
Monthly Subscription
for only
US$52.04
VAT not included
Stock Name Stock Symbol Market Stock Type
LAVA Therapeutics NV LVTX NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
0.05 1.83% 2.78 02:42:29
Open Price Low Price High Price Close Price Previous Close
2.78 2.78 2.91 2.73
more quote information »

Recent News

Date Time Source Heading
17/6/202206:05GLOBELAVA Therapeutics Highlights Encouraging Clinical Updates on..
15/6/202221:00GLOBELAVA Therapeutics Announces Two Appointments to its Board of..
07/6/202201:00TRMNJ.P. Morgan Thinks LAVA Therapeutics’ Stock is Going to..
03/6/202207:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
02/6/202221:00GLOBELAVA Therapeutics to Participate at the Jefferies Healthcare..
01/6/202221:00GLOBELAVA Therapeutics to Present Initial Phase 1/2a Clinical..
01/6/202206:05GLOBELAVA Therapeutics Announces Annual Meeting of Shareholders
19/5/202213:48TRMNLAVA Therapeutics (LVTX) Gets a Buy Rating from SVB..
17/5/202221:00GLOBELAVA Therapeutics Provides Business Update and Reports First..
12/5/202221:00GLOBELAVA Therapeutics Announces FDA IND Clearance for LAVA-051..
05/5/202221:00GLOBELAVA Therapeutics to Participate at the UBS Global..
03/5/202201:30TRMNLeerink Partners Thinks LAVA Therapeutics’ Stock is Going to..
28/4/202200:05GLOBELAVA Therapeutics to Present Updated LAVA-051 Clinical Data..
22/4/202220:16EDGARNotice of Effectiveness (effect)
13/4/202206:03EDGARSecurities Registration (foreign Private Issuer) (f-3)
29/3/202207:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
25/3/202202:11EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
24/3/202222:10SEEKLAVA Therapeutics GAAP EPS of -$0.38 misses by $0.01,..
24/3/202221:30GLOBELAVA Therapeutics Provides Business Update and Reports..
10/3/202222:30GLOBELAVA Therapeutics To Present at the Oppenheimer 32nd Annual..
08/3/202200:35GLOBELAVA Therapeutics Presents Initial LAVA-051 Clinical Data at..
02/2/202200:22SEEKLava Therapeutics begins dosing in phase 1/2a trial of..
01/2/202222:30GLOBELAVA Therapeutics Announces Treatment of First Patient in..
28/1/202223:00GLOBELava Therapeutics Announces Participation in the SVB Leerink..
19/1/202200:30GLOBELAVA Therapeutics Presents Preclinical Data on its..
08/1/202223:06TRMNAnalysts Offer Insights on Healthcare Companies: Argenx Se..
08/1/202203:00EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
21/12/202102:06GLOBECORRECTING AND REPLACING - LAVA Therapeutics to Present..
20/12/202123:00GLOBELAVA Therapeutics to Present Corporate Overview at 40th..
16/11/202108:24EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
16/11/202101:05SEEKLAVA Therapeutics reports Q3 results
15/11/202123:00GLOBELAVA Therapeutics Provides Business Update and Reports Third..
12/11/202102:08GLOBELAVA Therapeutics and The Antibody Society Present Emerging..
09/11/202122:30GLOBELAVA Therapeutics Expands Management Team with Three Key..
04/11/202122:00GLOBELAVA Therapeutics to Participate in the 12th Annual..
02/11/202122:00GLOBELAVA Therapeutics Announces Participation at Upcoming..
15/10/202123:26SEEKRIOT, BTBT and HUT among pre market gainers
15/10/202123:03DJNLAVA Therapeutics Gets FDA Orphan Designation for LAVA-051
15/10/202122:00GLOBELAVA Therapeutics Receives FDA Orphan Drug Designation for..
14/10/202105:51DJNLAVA Therapeutics Up 7% After Orphan Drug Designation
13/10/202123:32EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
08/10/202103:36GLOBECORRECTING and REPLACING: LAVA Therapeutics to Present its..
08/10/202102:31GLOBELAVA Therapeutics to Present its Bispecific Gamma Delta T..
17/8/202106:59EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
04/8/202107:42SEEKCERS, IDN, ZY and CDLX among after hours movers
13/7/202121:44SEEKDosing underway in LAVA Therapeutics' Phase 1/2a trial of..
Your Recent History
NASDAQ
LVTX
LAVA Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220627 17:08:18